Search research articles
Contact Us
Filters
Showing results (81-90 of 84) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 84 results.
The Journal of Biological Chemistry
|
December 23, 1994
Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3
A Toker, M Meyer, K K Reddy, et al.
The Journal of Biological Chemistry
|
August 28, 1999
Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes
M L Standaert, G Bandyopadhyay, L Perez, et al.
FEBS Letters
|
November 20, 1998
Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I
S Marmiroli, A Bavelloni, I Faenza, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2015
Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
Shiri Weinstein, Itai A Toker, Rafi Emmanuel, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 84) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 84 results.
The Journal of Biological Chemistry
|
December 23, 1994
Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3
A Toker, M Meyer, K K Reddy, et al.
The Journal of Biological Chemistry
|
August 28, 1999
Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes
M L Standaert, G Bandyopadhyay, L Perez, et al.
FEBS Letters
|
November 20, 1998
Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I
S Marmiroli, A Bavelloni, I Faenza, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 25, 2015
Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
Shiri Weinstein, Itai A Toker, Rafi Emmanuel, et al.
Page
of 9